Epidauros, a provider of pharmacogenetic assays and services, will partner with Directif, a subsidiary of November AG based in
Bernried, Germany-based Epidauros said that it will market the LabChip to its established clientele of international pharmaceutical companies. Epidauros licensed a genetic polymorphism to Roche in November 2004 for use in its AmpliChip CYP450 test.
Financial details of the collaboration were not discussed.